Viewing nowCombinationEmpagliflozin and Metformin Tablets 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.

MFDS item code 202201398 · Approved 2022.04.04 · Insurance code 646005520
Improvement of glycemic control in adults with type 2 diabetes
This medication is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is particularly effective in patients whose blood sugar is not adequately controlled, and caution is needed concerning cardiovascular risks in patients with cardiovascular diseases. Therefore, this medication aids in controlling blood sugar and improving diabetes management.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is a combination treatment used for type 2 diabetes. Caution must be exercised as it can cause a rare but serious side effect known as lactic acidosis. Lactic acidosis occurs when there is an excessive accumulation of lactate in the body, with symptoms including malaise, muscle pain, shortness of breath, and abdominal pain. Additionally, when taken with insulin or sulfonylureas, there is a risk of hypoglycemia, necessitating frequent blood sugar checks and possible dosage adjustments. This medication should not be used in patients with moderate to severe renal impairment or suspected acute kidney injury. In cases of acute infections, dehydration, heart failure, or acute myocardial infarction, the use of this medication should be temporarily suspended, and it is safe to discontinue for a period before and after surgery. Patients with impaired liver function or those consuming excessive alcohol should also avoid this medication. This medication may increase the risk of urinary tract infections and genital infections; therefore, if related symptoms occur, immediate notification to medical personnel is required. Increased urination may occur, and caution is needed as hypotension or dehydration may arise due to fluid loss. Women who are pregnant or breastfeeding should not take this medication, and it is not recommended for children under 18 years of age. Elderly patients may have a higher likelihood of reduced kidney function, requiring regular monitoring of kidney function and avoidance of maximum dosage. In case of overdose, medical attention should be sought immediately as this medication can be removed via hemodialysis. Patients taking this medication should avoid alcohol, and if symptoms of hypoglycemia or lactic acidosis occur, they should consult a doctor immediately. Finally, this medication should be kept out of reach of children and stored in the original container to ensure quality maintenance.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container, protected from air and moisture. It is safest to store it at room temperature between 1°C and 30°C, avoiding extremes of heat or cold.
Yellowish-white, double convex, oval-shaped film-coated tablets
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.